|Bid||1.670 x 0|
|Ask||1.680 x 0|
|Day's Range||1.660 - 1.690|
|52 Week Range||1.360 - 4.500|
|Beta (5Y Monthly)||1.29|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 25, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||1.60|
Subscribe to Yahoo Finance Plus to view Fair Value for 1357.HKLearn more
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Dynavax Technologies Corporation (Nasdaq: DVAX) today reported that it has granted nonstatutory stock options to purchase an aggregate of 58,500 shares of Dynavax common stock as inducements to 5 newly-hired employees in connection with commencement of employment with the Company.
Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, today announced that it will participate in the following investor conferences.